Track topics on Twitter Track topics that are important to you
Oct 19 (Reuters) - Abbott Laboratories, which is in the process of acquiring St. Jude Medical Inc for $25 billion, reported third-quarter results that nudged past Wall Street estimates, driven by strength in its medical devices business.
Original Article: UPDATE 1-Abbott's third-quarter results edge past StreetNEXT ARTICLE
The 11th largest pharmaceutical company in the world, <!--LGfEGNT2Lhm-->Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the <!--LGfEGNT2Lhm-->medical device arm of the company, products of note ar...